Clinical effect of lafutidine (Protecadin) on the mild case of Reflux Disease (health care economic comparison of which it contrasts Lansoprazole)
Not Applicable
- Conditions
- reflux esophagitis
- Registration Number
- JPRN-UMIN000006162
- Lead Sponsor
- PROMISE study Society
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 160
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patient with gastroduodenal ulcer (ulcer scar is assumed to be acceptable) and cancer of upper gastroitestinal tract 2)Patient with barett's epithelium extends it to part by ..distal portion of esophagus.. exceed 3cm 3)Patient with past history of operation of upper gastrointestinal tract 4)Patient who had taken PPI and H2RA within 2weeks before endscopy 5)Severe disease in heart, liver and kidney 6)Drug allergy for laftidine, lansoprazole and other drugs 7)expectant mother, mother with breast-feeding 8)other not applicable person recognized by a doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method